Login / Signup

TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression.

C ZengY ZhangC LinW LiangJ ChenY ChenH XiaoY LiHongyu Guan
Published in: Journal of endocrinological investigation (2024)
Our results suggest that TFCP2L1 is a tumor suppressor and potential differentiation regulator, and might be a potential therapeutic target in thyroid cancer.
Keyphrases
  • transcription factor
  • human health
  • risk assessment